• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用决策树模型指导胰腺癌患者胰十二指肠切除术后的干预措施。

Guiding post-pancreaticoduodenectomy interventions for pancreatic cancer patients utilizing decision tree models.

作者信息

Wang Haixin, Shen Bo, Jia Peiheng, Li Hao, Bai Xuemei, Li Yaru, Xu Kang, Hu Pengzhen, Ding Li, Xu Na, Xia Xiaoxiao, Fang Yong, Chen Hebing, Zhang Yan, Yue Shutong

机构信息

Department of Cadre Medical, The First Medical Centre, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Department of Respiratory and Critical Care Medicine, The Eighth Medical Centre, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

出版信息

Front Oncol. 2024 May 30;14:1399297. doi: 10.3389/fonc.2024.1399297. eCollection 2024.

DOI:10.3389/fonc.2024.1399297
PMID:38873261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11169653/
Abstract

BACKGROUND

Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed in advanced stages, necessitating pancreaticoduodenectomy (PD) as a primary therapeutic approach. However, PD surgery can engender intricate complications. Thus, understanding the factors influencing postoperative complications documented in electronic medical records and their impact on survival rates is crucial for improving overall patient outcomes.

METHODS

A total of 749 patients were divided into two groups: 598 (79.84%) chose the RPD (Robotic pancreaticoduodenectomy) procedure and 151 (20.16%) chose the LPD (Laparoscopic pancreaticoduodenectomy) procedure. We used correlation analysis, survival analysis, and decision tree models to find the similarities and differences about postoperative complications and prognostic survival.

RESULTS

Pancreatic cancer, known for its aggressiveness, often requires pancreaticoduodenectomy as an effective treatment. In predictive models, both BMI and surgery duration weigh heavily. Lower BMI correlates with longer survival, while patients with heart disease and diabetes have lower survival rates. Complications like delayed gastric emptying, pancreatic fistula, and infection are closely linked post-surgery, prompting conjectures about their causal mechanisms. Interestingly, we found no significant correlation between nasogastric tube removal timing and delayed gastric emptying, suggesting its prompt removal post-decompression.

CONCLUSION

This study aimed to explore predictive factors for postoperative complications and survival in PD patients. Effective predictive models enable early identification of high-risk individuals, allowing timely interventions. Higher BMI, heart disease, or diabetes significantly reduce survival rates in pancreatic cancer patients post-PD. Additionally, there's no significant correlation between DGE incidence and postoperative extubation time, necessitating further investigation into its interaction with pancreatic fistula and infection.

摘要

背景

胰腺导管腺癌(PDAC)常在晚期被诊断出来,这使得胰十二指肠切除术(PD)成为主要的治疗方法。然而,PD手术可能引发复杂的并发症。因此,了解电子病历中记录的影响术后并发症的因素及其对生存率的影响,对于改善患者的总体预后至关重要。

方法

总共749例患者被分为两组:598例(79.84%)选择机器人胰十二指肠切除术(RPD),151例(20.16%)选择腹腔镜胰十二指肠切除术(LPD)。我们使用相关性分析、生存分析和决策树模型来找出术后并发症和预后生存方面的异同。

结果

以侵袭性著称的胰腺癌通常需要胰十二指肠切除术作为有效的治疗方法。在预测模型中,BMI和手术时长都很重要。较低的BMI与较长的生存期相关,而患有心脏病和糖尿病的患者生存率较低。像胃排空延迟、胰瘘和感染等并发症在手术后密切相关,这引发了对其因果机制的猜测。有趣的是,我们发现鼻胃管拔除时间与胃排空延迟之间没有显著相关性,这表明在减压后应及时拔除。

结论

本研究旨在探索PD患者术后并发症和生存的预测因素。有效的预测模型能够早期识别高危个体,从而进行及时干预。较高的BMI、心脏病或糖尿病会显著降低胰腺癌患者PD术后的生存率。此外,胃排空延迟的发生率与术后拔管时间之间没有显著相关性,有必要进一步研究其与胰瘘和感染的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/d64eca94d952/fonc-14-1399297-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/9b5dcd046dbc/fonc-14-1399297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/c7f7010b007f/fonc-14-1399297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/abed77885166/fonc-14-1399297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/d64eca94d952/fonc-14-1399297-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/9b5dcd046dbc/fonc-14-1399297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/c7f7010b007f/fonc-14-1399297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/abed77885166/fonc-14-1399297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81ba/11169653/d64eca94d952/fonc-14-1399297-g004.jpg

相似文献

1
Guiding post-pancreaticoduodenectomy interventions for pancreatic cancer patients utilizing decision tree models.利用决策树模型指导胰腺癌患者胰十二指肠切除术后的干预措施。
Front Oncol. 2024 May 30;14:1399297. doi: 10.3389/fonc.2024.1399297. eCollection 2024.
2
Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis.腹腔镜与开腹胰十二指肠切除术治疗胰导管腺癌:倾向评分匹配分析。
Cancer Commun (Lond). 2019 Oct 28;39(1):66. doi: 10.1186/s40880-019-0410-8.
3
Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.胃排空延迟与接受胰头十二指肠切除术治疗胰腺腺癌的患者的死亡率增加相关。
Updates Surg. 2023 Apr;75(3):523-530. doi: 10.1007/s13304-022-01404-4. Epub 2022 Oct 30.
4
Delayed gastric emptying after laparoscopic pancreaticoduodenectomy: a single-center experience of 827 cases.腹腔镜胰十二指肠切除术后胃排空延迟:单中心 827 例经验。
BMC Surg. 2024 May 11;24(1):145. doi: 10.1186/s12893-024-02447-7.
5
A comprehensive strategy for perioperative care of pancreaticoduodenectomy according to the risk stratification by pancreatic fistula and delayed gastric emptying.根据胰瘘和胃排空延迟风险分层制定的胰十二指肠切除术围手术期综合护理策略。
Asian J Surg. 2022 Jan;45(1):172-178. doi: 10.1016/j.asjsur.2021.04.022. Epub 2021 Apr 28.
6
Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy.胰胃吻合胰十二指肠切除术后胰瘘和胃排空延迟的危险因素
J Am Coll Surg. 2007 Apr;204(4):588-96. doi: 10.1016/j.jamcollsurg.2007.01.018. Epub 2007 Mar 2.
7
What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?机器人胰十二指肠切除术治疗胰腺癌的真正获益是什么?
Expert Rev Gastroenterol Hepatol. 2024 Apr-May;18(4-5):133-139. doi: 10.1080/17474124.2024.2351398. Epub 2024 May 10.
8
Postoperative acute pancreatitis as a major determinant of postoperative delayed gastric emptying after pancreaticoduodenectomy.术后急性胰腺炎是胰十二指肠切除术后胃排空延迟的主要决定因素。
J Gastrointest Surg. 2006 Sep-Oct;10(8):1131-9. doi: 10.1016/j.gassur.2006.05.012.
9
Textbook oncologic outcomes are associated with increased overall survival in patients with pancreatic head cancer after undergoing laparoscopic pancreaticoduodenectomy.教科书式的肿瘤学结果与接受腹腔镜胰十二指肠切除术后的胰头癌患者总生存期延长相关。
World J Surg Oncol. 2024 Feb 6;22(1):43. doi: 10.1186/s12957-024-03322-8.
10
[Robotic and Laparoscopic Pancreaticoduodenectomy for the Elderly Patients-A Single Institutional Experience].老年患者的机器人与腹腔镜胰十二指肠切除术——单中心经验
Gan To Kagaku Ryoho. 2023 Dec;50(13):1688-1690.

本文引用的文献

1
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories.一种基于深度学习算法的胰腺癌风险预测方法。
Nat Med. 2023 May;29(5):1113-1122. doi: 10.1038/s41591-023-02332-5. Epub 2023 May 8.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Annual report to the nation on the status of cancer, part 1: National cancer statistics.国家癌症报告:癌症统计数据 1. 全国癌症统计数据概览
Cancer. 2022 Dec 15;128(24):4251-4284. doi: 10.1002/cncr.34479. Epub 2022 Oct 27.
4
The impact of venous resection in pancreatoduodectomy: A systematic review and meta-analysis.胰十二指肠切除术时静脉切除的影响:系统评价和荟萃分析。
Medicine (Baltimore). 2021 Oct 8;100(40):e27438. doi: 10.1097/MD.0000000000027438.
5
Complications After Pancreaticoduodenectomy.胰十二指肠切除术后并发症。
Surg Clin North Am. 2021 Oct;101(5):865-874. doi: 10.1016/j.suc.2021.06.011. Epub 2021 Jul 29.
6
Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy.分子外科切缘分析对胰十二指肠切除术后胰腺癌复发预测的影响。
Clin Epigenetics. 2021 Sep 16;13(1):172. doi: 10.1186/s13148-021-01165-8.
7
Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study.老年胰腺癌患者新辅助治疗的结果:对比、观察队列研究。
Br J Surg. 2021 Aug 19;108(8):976-982. doi: 10.1093/bjs/znab092.
8
Previous upper abdominal surgery is a risk factor for nasogastric tube reinsertion after pancreaticoduodenectomy.既往上腹部手术是胰十二指肠切除术后再次置放鼻胃管的危险因素。
Surgery. 2021 Oct;170(4):1223-1230. doi: 10.1016/j.surg.2021.03.059. Epub 2021 May 3.
9
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.吉西他滨/白蛋白紫杉醇与 FOLFIRINOX 用于晚期胰腺癌一线姑息治疗:倾向评分分析。
Eur J Cancer. 2021 Jul;151:3-13. doi: 10.1016/j.ejca.2021.03.040. Epub 2021 May 2.
10
Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer.临床数据预测模型,用于识别早期胰腺癌患者。
JCO Clin Cancer Inform. 2021 Mar;5:279-287. doi: 10.1200/CCI.20.00137.